This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Eisai R&d Management Co., Ltd.. Active years: 2018-2023.
Company Filing History:
Years Active: 2018-2023
Title: Jason S Simon: Innovator in Cancer Treatment
Introduction
Jason S Simon is a notable inventor based in Woodcliff Lake, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. With a total of 2 patents, Simon is dedicated to improving therapeutic options for patients suffering from thyroid and kidney cancers.
Latest Patents
Simon’s latest patents focus on biomarkers that predict and assess the responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds. These biomarkers are crucial for determining a subject's responsiveness to therapies that include lenvatinib or its pharmaceutically acceptable salts, such as lenvatinib mesylate. The methods and compositions described in his patents are instrumental in selecting appropriate treatment modalities for individuals diagnosed with cancer, suspected of having cancer, or at risk of developing cancer.
Career Highlights
Jason S Simon is currently associated with Eisai R&D Management Co., Ltd. His work in this organization has allowed him to further his research and contribute to advancements in cancer treatment. His innovative approach has garnered attention in the medical community.
Collaborations
Simon collaborates with esteemed colleagues, including Yasuhiro Funahashi and Tadashi Kadowaki. Their combined expertise enhances the research and development of effective cancer therapies.
Conclusion
Jason S Simon is a prominent figure in the field of cancer research, with a focus on developing biomarkers for improved treatment outcomes. His contributions are vital for advancing therapeutic strategies for cancer patients.